Immunization with antigen and interleukin 2 in vivo overcomes Ir gene low responsiveness
about
Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections.Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine.Strategies to use immune modulators in therapeutic vaccines against cancerStrategies for designing and optimizing new generation vaccines.The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.A push-pull vaccine strategy using Toll-like receptor ligands, IL-15, and blockade of negative regulation to improve the quality and quantity of T cell immune responses.Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.Cytokines as adjuvants for avian vaccines.IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases.Adjuvant-dependent immune response to malarial transmission-blocking vaccine candidate antigens.Regulation by recombinant interleukin-2 of protective immunity against recurrent herpes simplex virus type 2 genital infection in guinea pigs.Protein antigenic structures recognized by T cells: potential applications to vaccine design.Molecular chimerization of Pasteurella haemolytica leukotoxin to interleukin-2: effects on cytokine and antigen function.Recombinant vaccines against ovine footrot.Development of vaccine strategies for the treatment of B-cell malignancies.Administration of recombinant interleukin 2 in vivo induces a polyclonal IgM response.Vaccinia-interleukin 2 recombinant virus or exogenous interleukin 2 does not alter the magnitude or immune response gene defects of the cytotoxic T-cell response to vaccinia virus in vivo.Protective immunity to Listeria monocytogenes elicited by immunization with heat-killed Listeria and IL-12. Potential mechanism of IL-12 adjuvanticity.
P2860
Q33776155-52260BA9-FA3D-4FBC-B06C-EC004BD31492Q33867863-E09BE937-5264-40DB-9574-72464338A3E5Q34275601-DBE8210A-D1CE-4E34-82BC-89F0EBBCE05BQ34572198-71D69662-78AE-4916-A938-88385D517D72Q35190753-FDF03E2E-0EC2-4A70-B20A-D6084432D612Q35871793-0F22E58A-F9E3-4534-8DD8-F5FE76E7D66CQ35874803-803F99E2-1CCE-4ECD-A6B1-3C0215595357Q35953768-F89C6BED-7421-4FF5-946D-8591F9DADE92Q36091993-321EA4AF-0590-4C88-9C43-FD57F27AFCE5Q36231958-42EDE0F7-6B46-4274-A88D-CE73C5F93464Q36889622-E232E4FA-B16E-4357-8D06-2793FB153B5EQ38179198-77A7FA02-401D-4EB5-B290-CC29BF816B72Q40149284-BEBCA18C-72A2-496F-B44F-6F8FBF70295BQ40385025-043C4FEB-DAD0-4F80-9597-DDFA5B45D57FQ41669410-5247C9D3-E300-492E-8B15-4E1D284B10B7Q41890743-FB6B7A61-A32D-4BBB-A663-CD6EFFFCBADEQ43421663-B34B01DA-4533-404A-8D9E-34C1D7404915Q43721168-B5837B95-08C2-4C98-A034-2A57343540DF
P2860
Immunization with antigen and interleukin 2 in vivo overcomes Ir gene low responsiveness
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Immunization with antigen and interleukin 2 in vivo overcomes Ir gene low responsiveness
@ast
Immunization with antigen and interleukin 2 in vivo overcomes Ir gene low responsiveness
@en
type
label
Immunization with antigen and interleukin 2 in vivo overcomes Ir gene low responsiveness
@ast
Immunization with antigen and interleukin 2 in vivo overcomes Ir gene low responsiveness
@en
prefLabel
Immunization with antigen and interleukin 2 in vivo overcomes Ir gene low responsiveness
@ast
Immunization with antigen and interleukin 2 in vivo overcomes Ir gene low responsiveness
@en
P2093
P2860
P356
P1476
Immunization with antigen and interleukin 2 in vivo overcomes Ir gene low responsiveness
@en
P2093
Berzofsky JA
Kawamura H
Rosenberg SA
P2860
P304
P356
10.1084/JEM.162.1.381
P407
P577
1985-07-01T00:00:00Z